Skip to main content
OpenTrials
Completed

NCT Number: NCT04853394

Tajik Migrant Health Education Study

This study will test the efficacy of a peer-education prevention intervention to reduce risky drug, alcohol, and sexual behaviors among male Tajik labor migrants who inject drugs (MWID) while working in Moscow. The peer educator intervention will be compared to a health education control intervention. Each intervention consists of 5 weekly 2-hour small group sessions. Follow-up assessments will be conducted at 3, 6, 9, and 12 months after the intervention. It is hypothesized that, compared to MWID who receive the health education control intervention, those who receive the peer educator intervention will have a greater reduction in the frequency of risk behaviors. Similar effects are expected for network members of intervention participants.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Infections Behavior Blood-Borne Infections Communicable Diseases Digestive System Diseases Flaviviridae Infections Genital Diseases Health Behavior Health Risk Behaviors Hepatitis Hepatitis C Hepatitis, Viral, Human Immune System Diseases Immunologic Deficiency Syndromes Infections Lentivirus Infections Liver Diseases RNA Virus Infections Retroviridae Infections Risk Reduction Behavior Risk-Taking Risky Health Behavior Sexually Transmitted Diseases Sexually Transmitted Diseases, Viral Urogenital Diseases Virus Diseases

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

PRISMA Research Center

Moscow, Russia

About this study

The investigators will recruit male Tajik migrants who inject drugs from 12 different sites in Moscow, including bazaars and other work sites. In both study arms, the recruited men (index participants) will be required to recruit two eligible MWID peers for interviews prior to being interviewed themselves. Participants will be randomly assigned to either the peer educator intervention program or the health education intervention program. After peer-recruited network members are enrolled and interviewed, the index participant will participate in the peer educator training or the control group activities. All participants and recruited network members will then be followed and re-interviewed at 3-month intervals for one year to assess changes in risky drug, alcohol, and sexual behaviors due to intervention participation and through diffusion to network members. The investigators will also collect data from voluntary HIV and HCV testing conducted at 6 months (HCV only) and at 12 months (HIV and HCV) post-intervention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • adult Tajik man
  • injected drugs in past 30 days
  • living and working as migrant laborer in Moscow

Exclusion criteria

  • does not intend to stay in Moscow for the next 12 months

Treatment and study plan

MASLIHAT

Behavioral

peer educator intervention

TANSIHAT

Behavioral

health education intervention

Primary outcomes

  1. Syringe Sharing

    Time frame: 3 months

    injected with a previously used syringe

  2. Sex Without Condom

    Time frame: 3 months

    vaginal or anal sex without a condom in the past 3 months

  3. Alcohol Use

    Time frame: 30 days

    Number of days drinking alcohol in past month

Secondary outcomes

  1. HIV Infection

    Time frame: 12 months

    incident HIV infection

  2. Hepatitis C Infection

    Time frame: 12 months

    incident hepatitis C virus (HCV) infection

Other outcomes

  1. Injection Equipment Sharing

    Time frame: 3 months

    used shared injection equipment

Sponsors and collaborators

Lead sponsor

University of Illinois at Chicago

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)
  • Prisma Research Center

Registry information

Official study title

MASLIHAT Intervention for Tajik Male Migrants Who Inject Drugs

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Apr 21, 2021
Registry last updated
Dec 6, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.